Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Miao H, Wu T, Purohit T, Chen D, et al. Blood 2026 Mar 18:blood.2025031201. doi: 10.1182/blood.2025031201.

Read + Share

Amedeo Smart

Independent Medical Education

Miao H, Wu T, Purohit T, Chen D, et al. Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Blood 2026 Mar 18:blood.2025031201. doi: 10.1182/blood.2025031201.
PMID: 41849234